A Study of Avoralstat In Participants With Diabetic Macular Edema

Stopped early · Phase 1

Conditions studied: Diabetic Macular Edema (DME)

In brief

The goal of this study is to assess the safety and therapeutic potential of a single dose of avoralstat in adult participants with DME.

Key facts

Study ID

NCT07228559

Run by

BioCryst Pharmaceuticals

People needed

3

Starts

2025-10-02

Expected to finish

2026-04-17

Last updated by the study team

2026-05-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Investigative Site 6 — Sacramento, California, United States
• Investigative Site 7 — Katy, Texas, United States
• Investigative Site 8 — The Woodlands, Texas, United States
• Investigative Site 1 — Sydney, New South Wales, Australia
• Investigative Site 2 — Sydney, New South Wales, Australia
• Investigative Site 3 — Sydney, New South Wales, Australia
• Investigative Site 4 — Adelaide, South Australia, Australia
• Investigative Site 5 — Melbourne, Victoria, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.